Effect of the combination of BCc1 & Hep-S on hospitalized COVID-19 patients

Effect of the combination of BCc1 & Hep-S on the improvement of clinical & laboratory symptoms of hospitalized COVID-19 patients in a randomized, double-blind, clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170731035423N2

Enrollment

120

Registered

2020-06-12

Start date

2020-05-21

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group 1 – Medicine: chelated mixture named BCc1. Number & content: a 250 cc bottle containing 200 cc medicine in the form of syrup. Chemical mixture: polymerized organic a

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Hospitalized definite COVID-19 patients diagnosed by PCR & CT scan of the lungs Patients' filling out a consent form Patients won't be discharged within 48 hrs Patients' conditions won't be improving within 48 hrs

Exclusion criteria

Exclusion criteria: Pregnancy In lactation Addiction to alcohol or drugs Patients with transplants Patients with a record of type 1 diabetes Hereditary immunodeficiency

Design outcomes

Primary

Measure	Time frame
Hospitalization period. Timepoint: Hospitalization period. Method of measurement: Counting hospitalization days.;Mortality. Timepoint: Before and after being released. Method of measurement: Observation.;CT scan images of the lungs. Timepoint: Before hospitalization & 2 weeks after. Method of measurement: CT scan images.;Clinical indices. Timepoint: Before intervention, 3 & 6 days after intervention and before being released. Method of measurement: Questionnaire.;CT scan of the lungs. Timepoint: Before the start of the intervention, before being released & 2 weeks after. Method of measurement: CT scan machine.	—

Measure

Time frame

Hospitalization period. Timepoint: Hospitalization period. Method of measurement: Counting hospitalization days.;Mortality. Timepoint: Before and after being released. Method of measurement: Observation.;CT scan images of the lungs. Timepoint: Before hospitalization & 2 weeks after. Method of measurement: CT scan images.;Clinical indices. Timepoint: Before intervention, 3 & 6 days after intervention and before being released. Method of measurement: Questionnaire.;CT scan of the lungs. Timepoint: Before the start of the intervention, before being released & 2 weeks after. Method of measurement: CT scan machine.

—

Secondary

Measure	Time frame
CRP. Timepoint: Before intervention, 3 & 6 days after intervention and before being released. Method of measurement: Biochemical methods.;ESR. Timepoint: Before intervention, 3 & 6 days after intervention and before being released. Method of measurement: Biochemical methods.;Oxygen saturation in patients. Timepoint: Before intervention, every day after intervention and before being released. Method of measurement: Pulse oximetry.;CBC. Timepoint: Before intervention, 3 & 6 days after intervention and before being released. Method of measurement: Biochemical methods.;SGOT & SGPT enzymes. Timepoint: Before intervention & before being released. Method of measurement: Biochemical methods.;PCR test. Timepoint: Before intervention & before being released. Method of measurement: Molecular methods.	—

Measure

Time frame

CRP. Timepoint: Before intervention, 3 & 6 days after intervention and before being released. Method of measurement: Biochemical methods.;ESR. Timepoint: Before intervention, 3 & 6 days after intervention and before being released. Method of measurement: Biochemical methods.;Oxygen saturation in patients. Timepoint: Before intervention, every day after intervention and before being released. Method of measurement: Pulse oximetry.;CBC. Timepoint: Before intervention, 3 & 6 days after intervention and before being released. Method of measurement: Biochemical methods.;SGOT & SGPT enzymes. Timepoint: Before intervention & before being released. Method of measurement: Biochemical methods.;PCR test. Timepoint: Before intervention & before being released. Method of measurement: Molecular methods.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hafizi

Sodour Ahrar Shargh Knowledge-based Company

mhafizi@nanochelatingtechnology.com+98 21 8899 2123

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026